Back to Search
ANN HOOS, M.D.
M.D.
Family Medicine Physician
NPI: 1417965062Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
47222(GA)
Research & Publications (20)
Desmoid tumors of the head and neck--a clinical study of a rare entity.
PMID 11084643·Head Neck·2000
8-other
Giant cellular blue nevus of the anterior chest wall mimicking metastatic melanoma to the breast: a case report.
PMID 10962460·J Surg Oncol·2000
5-case
Societal preference values for advanced melanoma health states in the United Kingdom and Australia.
PMID 19603025·Br J Cancer·2009
8-other
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4.
PMID 19318477·Clin Cancer Res·2009
3-trial
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.
PMID 19259668·Cancer Immunol Immunother·2009
8-other
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.
PMID 18602688·Lancet·2008
3-trial
Toward the harmonization of immune monitoring in clinical trials: quo vadis?
PMID 17721782·Cancer Immunol Immunother·2008
8-other
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS.
PMID 18665147·Nat Clin Pract Oncol·2008
5-case
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
PMID 18281670·J Clin Oncol·2008
3-trial
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).
PMID 17721781·Cancer Immunol Immunother·2008
6-review
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
PMID 17916465·Vaccine·2007
6-review
A clinical development paradigm for cancer vaccines and related biologics.
PMID 17198079·J Immunother·2007
6-review
Using standardized video cases for assessment of medical communication skills: reliability of an objective structured video examination by computer.
PMID 16332467·Patient Educ Couns·2006
8-other
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
PMID 16847673·Cancer Chemother Pharmacol·2006
3-trial
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients.
PMID 16215718·Cancer Immunol Immunother·2006
3-trial
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
PMID 16943525·J Clin Oncol·2006
8-other
Assessment of medical communication skills by computer: assessment method and student experiences.
PMID 15271041·Med Educ·2004
8-other
Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside.
PMID 15603187·Dev Biol (Basel)·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2140 PEACHTREE RD NW STE 232
ATLANTA, GA 30309 - Phone
- (404) 231-4431
Quick Facts
- NPI
- 1417965062
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile